Early Day Motion·EDM 348
AVAILABILITY OF GLIVEC
8 December 200423 Signatures
Motion Text
That this House supports the guidance issued by the Department of Health ensuring that Glivec, a novel treatment for chronic myeloid leukaemia, is available on the NHS; and welcomes the recognition that has now been granted by the National Institute for Clinical Excellence, without restrictions, which ensures another step forward in the constant battle against this terrible disease.